Globe Newswire
MOUNTAIN VIEW, Calif., Oct. 25, 2026 (GLOBE NEWSWIRE) --
Through its Tango for Good initiative, the global live-streaming platform supports FRIDA Ukraine's mobile cancer screening program, bringing essential medical services to local communities.
Tango, a global social live-streaming platform connecting creators and audiences worldwide, has donated tens of thousands of dollars to support cancer detection and preventive healthcare services in Ukraine through its... (continue reading...)
Will California’s May ’27 AI Safety Mandate Collide with DFARS Frameworks (AI vs. SI?)—Military Tech Veterans Advise IT Corp Giants to Reconsider Software Defenses
FAIRFIELD, Calif., Oct. 25, 2026 (GLOBE NEWSWIRE) -- A major convergence of state laws and federal military directives is reshaping the technology sector. As the compliance countdown quickens toward the May 15, 2027 deadline for California Executive Order N-9-26, tech giants find themselves caught... (continue reading...)
Longer-term data reflecting nearly 4 years of follow-up show a further reduction in the risk of death from 14% to 37% for those initially treated with Libtayo, despite an 88% crossover from the placebo arm upon recurrence
New prospective analyses confirm sustained disease-free survival (DFS) benefit with adjuvant Libtayo, including in patients who are minimal residual disease (MRD) negative at baseline
The late-breaking data were presented during a rapid oral session... (continue reading...)
RIYADH, Saudi Arabia, Oct. 25, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is expanding virtual and alternative care pathways at its Jeddah hospital, giving patients greater flexibility in how they access specialized services while reducing the need for unnecessary hospital visits.
In 2025, virtual clinic visits at KFSH Jeddah reached 97,647, an increase of 12.1% from the previous year. At the same time, outpatient visits... (continue reading...)
- Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of 36.7% following progression on or after immunotherapy plus chemotherapy
- An early median progression-free survival of 6.9 months was observed
- Significant unmet need remains for patients who have progressed on an immunotherapy-containing regimen, with the average progression-free... (continue reading...)
More Globe Newswire
View Older Stories-
Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
-
Teck Provides Update on Highland Valley Copper Operations
-
Online Cricket ID App Publishes Overview of Changing Digital Cricket Information Needs Among Indian Fans
-
UK Financial Ltd Launches MAYA CHAIN and Begins Digital Asset Migration
-
Get Cricket IDs Announces Online Information Resources for Live Cricket Updates, Match Statistics and Mobile Platform Access
-
AI-119 Vulcan Force Solution Targets California's May 2027 Frontier AI Deadline (Veterans First for America)
-
AI-119 Vulcan Force Solution Targets California's May 2027 Frontier AI Deadline (Veterans First for America)
-
Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
-
Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
-
Widgets & Web Launches AI-Operated Investor Relations Websites for Public Companies at a Fixed $299 per Month
-
Widgets & Web Launches AI-Operated Investor Relations Websites for Public Companies at a Fixed $299 per Month
-
2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember
-
Thousands of Ontarians to Attend ‘Together for Publicly Funded Education’ Rallies
-
Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress
-
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
-
DEEP Robotics Unveils Five Research Advances in Embodied AI
-
JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
-
JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
-
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
-
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
-
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
-
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
-
AirTripMaker Launches Comprehensive Business Class Flight Routes Guide from the USA to 15 Major International Destinations and Regions
-
Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
-
Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
-
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
-
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
-
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
-
Yangguang News Launches Global Youth Short Video Campaign “Me, Tang Poetry, and AI”
-
World Famous Liquor Brands Sustainability Index Report (2026) Released
-
Rooted in the River, Renewed with the Times: Insights from the 2026 Chishui River Forum
-
Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
-
See It, Try It, Compare It: SIVP Brings CHERY’s “Technology. For Family” to Life
-
Vmake Labs Launches All-in-One Halloween Social Video Toolkit for SMBs
-
Amaggi Luxembourg International S.à r.l. Announces Expiration and Results of Its Cash Tender Offer for Up to U.S.$300 Million Aggregate Principal Amount of Its 5.250% Notes Due 2028
-
Urban Seed Logs Record Harvest in 15th Season, Sets 2027 Focus on Building an Organization That Lasts
-
SuperClean Restoration Of The Palm Beaches LLC Surpasses 100+ Google Reviews, Solidifying Its Reputation as the Most Trusted Name in Water Damage Restoration in Wellington, FL
-
Shalaan Umar is America’s Top Young Innovator 2026 as Young Inventors Earn Global Recognition for Breakthrough Innovations
-
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
-
Reid Collins & Tsai LLP Notifies Holders of Navios Maritime Holdings, Inc.’s Preferred ADS of Deficiencies in Navios’s Recent Tender Offer Documentation
-
Mirasol Resources Announces Option Grants
-
Clearwater Properties Broker Hannah Bruha Named a "Star on the Rise" by Montana Real Producers
-
Black Rock Coffee Bar Continues Expansion in California with New Rancho Cucamonga Location
-
LUNR Aerospace Corporation Obtains Receipt for Final Prospectus Accessible on SEDAR+
-
Cryptocurrency News: Remittix Pairs Its $33 Million Raise With a 300 Million RTX Burn as XRP Ledger’s November Update Revives a $10 XRP Price Prediction
-
Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026
-
BlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETF
-
Navios Maritime Holdings Inc. Extends Tender Offer for Its Series G and Series H American Depository Shares until 11:59 p.m. on November 2, 2026
-
Kelvin Veras Real Estate Announces 16 Closed Transactions in Its First Year in New Jersey
-
Itafos Announces Release Date for Q3 2026 Results and Business Update Webcast


